rhodamine 123 has been researched along with clenbuterol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, H; Fawcett, JP; Gu, J; Guo, Y; Liu, J; Ma, W; Sun, Y; Wang, T; Yang, J; Yang, Y; Yang, Z | 1 |
1 other study(ies) available for rhodamine 123 and clenbuterol
Article | Year |
---|---|
Trantinterol, a novel β2-adrenoceptor agonist, noncompetitively inhibits P-glycoprotein function in vitro and in vivo.
Topics: Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Antibodies, Monoclonal; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Biological Transport; Caco-2 Cells; Clenbuterol; Cyclosporine; Digoxin; Dogs; Drug Evaluation, Preclinical; Humans; Madin Darby Canine Kidney Cells; Male; Paclitaxel; Rats; Rats, Wistar; Rhodamine 123 | 2015 |